EPIM-002

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameEPIM-002
Drug Alias NameEPIM-002
ClassificationBiologics
Mechanisms of ActionInterleukin-2 receptor beta chain agonistsT lymphocytes stimulants
TargetsInterleukin-2 receptor beta chain
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElpiscience (Shanghai) Biopharma Ltd
China Registration ClassN/A

Develop Information

Active CompaniesElpiscience (Shanghai) Biopharma Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A